Cargando…
Does chronic metformin therapy offer cardiomyoprotection in coronary artery bypass grafting surgery patients? A case-control study
Autores principales: | Delaporte, A, Hacquebard, JP, Origer, P, Pastijn, I, Maatouk, M, Germay, O, Stevens, E, Kapessidou, P, Roman, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642887/ http://dx.doi.org/10.1186/cc12390 |
Ejemplares similares
-
Anesthetic Management of a Voluminous Left Atrial Myxoma Resection in a 19 Weeks Pregnant with Atypical Clinical Presentation
por: Alexis, Alexandros, et al.
Publicado: (2019) -
Does preoperative beta-blocker offer myocardial protection during
coronary artery bypass grafting?
por: Rocha, Bruno da Costa
Publicado: (2013) -
Comparison of endothelial function of coronary artery bypass grafts in diabetic and nondiabetic patients: Which graft offers the best?
por: Gür, Demet Özkaramanlı, et al.
Publicado: (2016) -
Does cardiopulmonary bypass increase the risk of postoperative acute kidney injury after coronary artery bypass grafting?
por: Karmali, A, et al.
Publicado: (2015) -
Outcome and Graft Patency in Coronary Artery Bypass Grafting with Coronary Endarterectomy
por: Nemati, Mohammad Hassan, et al.
Publicado: (2015)